July 2023
Seroprevalence and risk factors associated with Toxoplasma gondii infection among pregnant women in Ile Ife, Southwestern Nigeria
This study investigated the seroprevalence of anti-Toxoplasma IgG and IgM antibodies as well as associated risk factors among pregnant women attending ante-natal care clinics in Ile Ife, Southwestern, Nigeria. A cross sectional hospital study was carried out in three major health care facilities within the study area between June and October, 2019. Three hundred and twenty pregnant women aged between 14-50 years...
August 2023
Molecular mechanism of Clofazimine resistance in tuberculosis
Drug resistance which is at present the main impendence to global tuberculosis (TB) control and drug- resistant (DR) activity of Mycobacterium tuberculosis in various strains have become the major challenge worldwide. Nowadays, many researchers use different antibiotics for treatment of DR-TB which are often not well tolerated and not adequately efficient. A large group study from various research published in different...
September 2023
Prevalence and socio-demographic determinants of malaria among febrile under- five children in Abobo district, Southwest Ethiopia: Cross-sectional study
Malaria ranks among Ethiopia's top ten causes of illness and mortality among children under five. The disease continues to pose a severe public health risk in malaria-endemic regions like the Abobo district. Information on malaria prevalence and its determinants among under-five year’s children in the Abobo district is missing. A facility-based cross-sectional study was conducted at Abobo Catholic Health...
November 2023
Current profile of post-vaccination humoral signature of SARS-CoV-2 in Abidjan healthcare workers vaccinated against COVID-19 after the COVAX initiative in Côte d’Ivoire
COVID-19, caused by SARS-CoV-2, has been the subject of unprecedented research, leading to a pandemic that urgently required effective vaccines to stop its spread. Despite the effectiveness of these vaccines, SARS-CoV-2 transmission continued, prompting questions about the immune response to SARS-CoV-2. Two years after the COVAX initiative in Cote D'ivoire, a study was conducted to assess the humoral response...
Advertisement
Advertisement